Edison Pharmaceuticals
Edison Pharmaceuticals, based in Mountain View, US, develops treatments for rare and neglected diseases.
Founded
2005Edison Pharmaceuticals, based in Mountain View, US, develops treatments for rare and neglected diseases.
Edison Pharmaceuticals, founded in Mountain View, United States, is dedicated to developing innovative treatments for rare and neglected diseases. The company's core mission is to improve the quality of life for children and adults suffering from these conditions through cutting-edge medical research and drug development. Edison Pharmaceuticals focuses on creating novel therapeutics that address unmet medical needs, aiming to bring hope and effective solutions to patients and their families.
Notable figures affiliated with Edison Pharmaceuticals include leading scientists and medical researchers who specialize in rare diseases. The company has attracted significant investment from venture capital firms committed to advancing healthcare innovations. Edison Pharmaceuticals has achieved key milestones in clinical trials, demonstrating promising results in the efficacy of their treatments. Their work has had a substantial impact on the rare disease community, providing new avenues for treatment where few options previously existed.
Companies similar to Edison Pharmaceuticals include Edimer Pharmaceuticals, Soleno Therapeutics, Escient Pharmaceuticals and Katana Pharmaceuticals.
Edison Pharmaceuticals was founded in 2005.
Edison Pharmaceuticals' headquarters is located in Mountain View, CA, US.
Edison Pharmaceuticals' most recent funding round was for $50M (USD) in March 2014.
As of Mar 27, 2014, Edison Pharmaceuticals has disclosed funding of $90.6M (USD). Undisclosed round amounts are excluded.
Edison Pharmaceuticals has 125 employees as of Feb 5, 2024.
Katana Pharmaceuticals
